POTENCY COMPARISON OF PEPTIDOMIMETIC INHIBITORS AGAINST HIV-1 AND HIV-2 PROTEINASES: DESIGN OF EQUIPOTENT LEAD COMPOUNDS

作者: Jan Weber , Pavel Majer , Jaroslav Litera , Jan Urban , Milan Souček

DOI: 10.1006/ABBI.1997.9945

关键词: PeptidomimeticOrders of magnitude (mass)Scissile bondStatineAmidePolyproteinsChemistryGlutamic acidStereochemistryIsostere

摘要: Abstract HIV-1 and HIV-2 proteinases (PR) are responsible for the processing of viral polyproteins, a step that is crucial formation infectious virus particles. PR represents one most important targets antiviral chemotherapy. Inhibitors usually exhibit 10- to 100-fold weaker affinity PR. In order design subnanomolar inhibitors both PRs, we prepared series compounds varying in type scissile bond replacement as well P1, P1′, P2′ side chains. While containing reduced amide, hydroxyethylamine statine isosteres had K i values range 10 −10 –10 −9 m against PR; their activities were several orders magnitude lower. Glutamic acid was identified be optimal residue PRs. shown more sensitive Glu→Gln replacement. Using this data set able prepare hydroxyethylene isostere equipotent

参考文章(28)
A.M. Mulichak, J.O. Hui, A.G. Tomasselli, R.L. Heinrikson, K.A. Curry, C.S. Tomich, S. Thaisrivongs, T.K. Sawyer, K.D. Watenpaugh, The crystallographic structure of the protease from human immunodeficiency virus type 2 with two synthetic peptidic transition state analog inhibitors. Journal of Biological Chemistry. ,vol. 268, pp. 13103- 13109 ,(1993) , 10.1016/S0021-9258(19)38625-9
A.G. Tomasselli, J.O. Hui, T.K. Sawyer, D.J. Staples, C. Bannow, I.M. Reardon, W.J. Howe, D.L. DeCamp, C.S. Craik, R.L. Heinrikson, Specificity and inhibition of proteases from human immunodeficiency viruses 1 and 2. Journal of Biological Chemistry. ,vol. 265, pp. 14675- 14683 ,(1990) , 10.1016/S0021-9258(18)77355-9
A D Richards, L H Phylip, W G Farmerie, P E Scarborough, A Alvarez, B M Dunn, P H Hirel, J Konvalinka, P Strop, L Pavlickova, Sensitive, soluble chromogenic substrates for HIV-1 proteinase. Journal of Biological Chemistry. ,vol. 265, pp. 7733- 7736 ,(1990) , 10.1016/S0021-9258(19)38989-6
J.Chris Culberson, Bruce L. Bush, Vinod V. Sardana, [21] Qualitative study of drug resistance in retroviral protease using structural modeling and site-directed mutagenesis Methods in Enzymology. ,vol. 241, pp. 385- 394 ,(1994) , 10.1016/0076-6879(94)41075-5
F. William Studier, Alan H. Rosenberg, John J. Dunn, John W. Dubendorff, Use of T7 RNA polymerase to direct expression of cloned genes. Methods in Enzymology. ,vol. 185, pp. 60- 89 ,(1990) , 10.1016/0076-6879(90)85008-C
M. Dixon, The determination of enzyme inhibitor constants Biochemical Journal. ,vol. 55, pp. 170- 171 ,(1953) , 10.1042/BJ0550170
Jill C. Heimbach, Victor M. Garsky, Stuart R. Michelson, Richard A.F. Dixon, Irving S. Sigal, Paul L. Darke, Affinity purification of the HIV-1 protease Biochemical and Biophysical Research Communications. ,vol. 164, pp. 955- 960 ,(1989) , 10.1016/0006-291X(89)91762-2
Martin Andreánsky, Olga Hrušková-Heidingsfeldová, Juraj Sedláčeka, Jan Konvalinka, Ivo Bláha, Petr Ječmen, Magda Hořejši, Petr Štrop, Milan Fábry, High-level expression of enzymatically active bovine leukemia virus proteinase in E. coli FEBS Letters. ,vol. 287, pp. 129- 132 ,(1991) , 10.1016/0014-5793(91)80032-X
J. Sedlacek, M. Fabry, M. Horejsi, J. Brynda, R.B. Luftig, P. Majer, A Rapid Screening Method for Biological Activity of Human Immunodeficiency Virus Proteinase Inhibitors by Using a Recombinant DNA-Derived Bacterial System Analytical Biochemistry. ,vol. 215, pp. 306- 309 ,(1993) , 10.1006/ABIO.1993.1593
Israel Schechter, Arieh Berger, On the size of the active site in proteases. I. Papain Biochemical and Biophysical Research Communications. ,vol. 27, pp. 157- 162 ,(1967) , 10.1016/S0006-291X(67)80055-X